Page 56 - 2019_11 Resto del Mondo-web
P. 56

K.N. Ward et al.
detection of human herpesvirus 6 DNA in serum. J Clin Microbiol. 2008;46(8):2700- 2706.
23. Cassina G, Russo D, De BD, Broccolo F, Lusso P, Malnati MS. Calibrated real-time polymerase chain reaction for specific quan- titation of HHV-6A and HHV-6B in clinical samples. J Virol Methods. 2013;189(1):172- 179.
24. de Pagter PJ, Schuurman R, de Vos NM, Mackay W, van Loon AM. Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. J Clin Microbiol. 2010;48(7):2536-2540.
25. Purev E, Winkler T, Danner RL, et al. Engraftment of donor cells with germ-line integration of HHV6 mimics HHV6 reacti- vation following cord blood/haplo trans- plantation. Blood. 2014;124(7):1198-1199.
26. Hubacek P, Maalouf J, Zajickova M, et al. Failure of multiple antivirals to affect high HHV-6 DNAaemia resulting from viral chro- mosomal integration in a case of severe aplastic anaemia. Haematologica. 2007;92 (10):e98-e100.
27. Jeulin H, Guery M, Clement L, et al. Chromosomally integrated HHV-6: slow decrease of HHV-6 viral load after hematopoietic stem-cell transplantation. Transplantation. 2009;88(9):1142-1143.
28. Hubacek P, Virgili A, Ward KN, et al. HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneu- monitis. Br J Haematol. 2009;145(3):394- 398.
29. Sedlak RH, Cook L, Huang ML, et al. Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem. 2014;60(5):765-772.
30. Lau YL, Peiris M, Chan GC, Chan AC, Chiu D, Ha SY. Primary human herpes virus 6 infection transmitted from donor to recipi- ent through bone marrow infusion. Bone Marrow Transplant. 1998;21(10):1063-1066.
31. Muramatsu H, Watanabe N, Matsumoto K, et al. Primary infection of human her- pesvirus-6 in an infant who received cord blood SCT. Bone Marrow Transplant. 2009;43(1):83-84.
32. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infec- tion in a bone marrow-transplant recipient. N Engl J Med. 1994;330(19):1356-1360.
33. Zerr DM. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol. 2006;37 Suppl 1:S52-S56.
34. Zerr DM, Ogata M. HHV-6A and HHV-6B in Recipients of Hematopoietic Cell Transplantation. In: Flamand L, Lautenschlager I, Krueger G, Ablashi D, edi- tors. HHV-6A, HHV-6B & HHV-7 Diagnosis and Clinical Management. 3rd ed. San Francisco: Elsevier; 2014.
35. Hill JA, Sedlak RH, Zerr DM, et al. Prevalence of chromosomally integrated human herpesvirus 6 in patients with human herpesvirus 6-central nervous sys- tem dysfunction. Biol Blood Marrow Transplant. 2015;21(2):371-373.
36. Ogata M, Oshima K, Ikebe T, et al. Clinical characteristics and outcome of human her- pesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52(11):1563- 1570.
37. Noguchi T, Yoshiura T, Hiwatashi A, et al. CT and MRI findings of human herpesvirus 6-associated encephalopathy: comparison
with findings of herpes simplex virus encephalitis. AJR Am J Roentgenol. 2010; 194(3):754-760.
38. Provenzale JM, van LK, White LE. Clinical and imaging findings suggesting human her- pesvirus 6 encephalitis. Pediatr Neurol. 2010;42(1):32-39.
39. Bhanushali MJ, Kranick SM, Freeman AF, et al. Human herpes 6 virus encephalitis com- plicating allogeneic hematopoietic stem cell transplantation. Neurology. 2013;80(16): 1494-1500.
40. Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P. HHV-6 encephalitis in umbilical cord blood trans- plantation: a systematic review and meta- analysis. Bone Marrow Transplant. 2013;48 (4):574-580.
41. Zerr DM, Fann JR, Breiger D, et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood. 2011;117 (19):5243-5249.
42. Hill JA, Boeckh MJ, Sedlak RH, Jerome KR, Zerr DM. Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation. J Clin Virol. 2014;61(2):289-292.
43. Hill JA, Boeckh M, Leisenring WM, et al. Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation. Bone Marrow Transplant. 2015;50(10):1348-1351.
44. Ueki T, Hoshi K, Hiroshima Y, et al. Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplanta- tions. Int J Hematol. 2018;107(3):363-372.
45. Zerr DM, Boeckh M, Delaney C, et al. HHV- 6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18(11): 1700-1708.
46. Dulery R, Salleron J, Dewilde A, et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large- scale clinical study. Biol Blood Marrow Transplant. 2012;18(7):1080-1089.
47. Olson AL, Dahi PB, Zheng J, et al. Frequent human herpesvirus-6 viremia but low inci- dence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biol Blood Marrow Transplant. 2014;20(6):787-793.
48. Ogata M, Satou T, Kadota J, et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multi- center, prospective study. Clin Infect Dis. 2013;57(5):671-681.
49. Hill JA, Koo S, Guzman Suarez BB, et al. Cord-blood hematopoietic stem cell trans- plant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant. 2012;18(11):1638-1648.
50. Ogata M, Fukuda T, Teshima T. Human her- pesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transplant 2015; 50(8):1030-1036.
51. Perruccio K, Sisinni L, Perez-Martinez A, et al. High Incidence of Early Human Herpesvirus-6 Infection in Children Undergoing Haploidentical Manipulated Stem Cell Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant. 2018;24(12):2549-2557.
52. Howell KB, Tiedemann K, Haeusler G, et al. Symptomatic generalized epilepsy after HHV6 posttransplant acute limbic
encephalitis in children. Epilepsia. 2012;53
(7):e122-e126.
53. Raspall-Chaure M, Armangue T, Elorza I,
Sanchez-Montanez A, Vicente-Rasoamalala M, Macaya A. Epileptic encephalopathy after HHV6 post-transplant acute limbic encephalitis in children: confirmation of a new epilepsy syndrome. Epilepsy Res. 2013;105(3):419-422.
54. Isomura H, Yoshida M, Namba H, et al. Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakary- ocytic colony formation in vitro. J Gen Virol. 2000;81(Pt 3):663-673.
55. Ljungman P, Wang FZ, Clark DA, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogene- ic stem cell transplant patients. Br J Haematol. 2000;111(3):774-781.
56. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2005;40(7):932-940.
57. Lagadinou ED, Marangos M, Liga M, et al. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation success- fully treated with foscarnet. Transpl Infect Dis. 2010;12(5):437-440.
58. Le Bourgeois A, Labopin M, Guillaume T, et al. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults. Exp Hematol. 2014;42(11):945-954.
59. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human her- pesvirus-6 infection after marrow transplan- tation. Lancet. 1991;338(8760):147-149.
60. Cone RW, Hackman RC, Huang ML, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone mar- row transplantation. N Engl J Med. 1993; 329(3):156-161.
61. Buchbinder S, Elmaagacli AH, Schaefer UW, Roggendorf M. Human herpesvirus 6 is an important pathogen in infectious lung dis- ease after allogeneic bone marrow trans- plantation. Bone Marrow Transplant. 2000;26(6):639-644.
62. Nishimaki K, Okada S, Miyamura K, et al. The possible involvement of human her- pesvirus type 6 in obliterative bronchiolitis after bone marrow transplantation. Bone Marrow Transplant. 2003;32(11):1103-1105.
63. Seo S, Renaud C, Kuypers JM, et al. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies. Blood. 2015;125(24):3789-3797.
64. Hill JA, Myerson D, Sedlak RH, Jerome KR, Zerr DM. Hepatitis due to human her- pesvirus 6B after hematopoietic cell trans- plantation and a review of the literature. Transpl Infect Dis. 2014;16(3):477-483.
65. Kuribayashi K, Matsunaga T, Iyama S, et al. Human herpesvirus-6 hepatitis associated with cyclosporine-A encephalitis after bone marrow transplantation for chronic myeloid leukemia. Intern Med. 2006;45(7): 475-478.
66. Crocchiolo R, Giordano L, Rimondo A, et al. Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogene- ic stem cell transplantation from haploiden- tical donor. J Clin Virol. 2016;84: 24-26.
67. Tormo N, Solano C, de la Camara R, et al. An assessment of the effect of human her-
2162
haematologica | 2019; 104(11)


































































































   54   55   56   57   58